Mesothelioma.com Resources for Patients and their Families
Request Free Guide

The MCA Blog

Connecting with others one story at a time Survivor Ribbon

Results for “Mesothelioma Treatment”

FDA Approves New Mesothelioma Treatment for the First Time in 15 Years

FDA Approves New Mesothelioma Treatment for the First Time in 15 Years

Malignant mesothelioma is an aggressive disease that is most often diagnosed in the later stages, at stage 3 or stage 4. Late-stage diagnoses limit treatment options for the patient, typically eliminating the possibility of radical surgeries. Multimodal therapy is the most common treatment for mesothelioma cancer, consisting of a combination of surgery, chemotherapy, and/or radiation. The possibility of multimodal therapy or what combination is used depends on a case-by-case basis.

Continue Reading »

Mesothelioma Survivor Heather Von St. James Reflects on Mother’s Day

Mesothelioma Survivor Heather Von St. James Reflects on Mother’s Day

In true mom fashion, my mother announces, “I’m going to be your mother now…” and dispenses her advice, which is usually right on the money. This was never more true in my life than when I got pregnant with my only child. My pregnancy was easy, but things in my life at the time warranted my mom using that phrase “I’m going to be your mother now” more than once.

Continue Reading »

New Study Identifies Six Factors Associated with Improved Mesothelioma Survival

New Study Identifies Six Factors Associated with Improved Mesothelioma Survival

Improving mesothelioma survival rates has been at the forefront of research for years, as the cancer has long been recognized for its poor prognosis due to a number of factors like difficulties in early detection and aggressive cell types. A recent study from the University of Pittsburgh has discovered six factors that they believe are associated with improved survival among mesothelioma patients and can help drive future research efforts to improve patient life expectancy. Currently, most mesothelioma patients live an average of 12 – 21 months following diagnosis. The team from the University of Pittsburgh set out to understand why patient survival varies so widely to help pinpoint research areas and drive future clinical trials.

Continue Reading »

New Clinical Trial Will Test WT1 Immunotherapy Drug with Nivolumab for Recurrent Mesothelioma

Researchers have found that recurrent rates for mesothelioma can vary widely, with some studies finding recurrence rates after treatment ranging from 10 – 72%. Even patients diagnosed in the earlier stages and who are able to undergo aggressive multimodal treatment have been found to experience recurrence. Because of the rather high likelihood of the cancer recurring, a heavy focus of mesothelioma research is finding optimal second- and third-line treatments for patients who have previously been treated and either experience recurrence or their cancer is unresponsive.

Continue Reading »

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

The 2019 International Symposium on Malignant Mesothelioma Brings Experts and Patients Together

From March 25th – 27th, the Mesothelioma Applied Research Foundation will host its annual International Symposium on Malignant Mesothelioma in Bethesda, Maryland. The Meso Foundation has organized the event since 2004 to help bring the mesothelioma community together, offering patients and loved ones insight to the latest treatments and research, facetime with renowned mesothelioma experts, and the opportunity to connect with others facing similar experiences.

Continue Reading »

Resources for Mesothelioma Patients and Their Families

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

Two Clinical Trials Show Potential of Opdivo for Recurrent Mesothelioma

One of the prominent areas of mesothelioma research today is around the development of an effective, tolerable, second-line treatment for recurrent cases. Studies have shown mesothelioma recurrence is highly prevalent, even among patients who are able to undergo aggressive primary therapy, like surgery. Some studies have noted recurrence rates ranging from 10 – 72% of patients.

Continue Reading »

How Dropping DNA into Water May Reveal Mesothelioma

How Dropping DNA into Water May Reveal Mesothelioma

Scientists at the University of Queensland in Australia have been working to find a cancer test that will detect cancer sooner, allowing patients to begin treatment earlier and improve their prognosis. This is particularly influential for rare cancers like malignant mesothelioma that are difficult to detect. Early detection is the best way to improve mesothelioma prognosis, stressing the need to find better diagnostic tools.

Continue Reading »

Dealing With a Cancer Diagnosis or Treatment During the Holidays

Dealing With a Cancer Diagnosis or Treatment During the Holidays

The holidays can be magical and stressful, make you thankful or hate everything. But when you add in a cancer diagnosis, treatment, or a hospital stay, or any illness to the season, you end up dealing with so much more. The season comes with some pretty high expectations and along with that, equal disappointment. I learned LONG ago to tamper expectations and try not to get carried away, but it isn’t always that easy.

Continue Reading »

Study Finds Radiation Before Surgery Can Make Immunotherapy More Effective for Mesothelioma

Study Finds Radiation Before Surgery Can Make Immunotherapy More Effective for Mesothelioma

Mesothelioma is often treated with a multimodal therapy of surgery, chemotherapy, and radiation therapy. Though these treatments are considered the standards of care, as curative and palliative options, researchers have debated the exact role of radiation for mesothelioma over the years. Some studies have suggested the therapy is not effective and mesothelioma tumors may be resistant to the treatment overall. Others have claimed that the treatment is best used palliatively to shrink tumors and help alleviate symptoms.

Continue Reading »

Doctors, Patients Convene at NYC Mesothelioma Symposium

Doctors, Patients Convene at NYC Mesothelioma Symposium

The Mesothelioma Applied Research Foundation recently held its International Symposium on Malignant Mesothelioma in New York City, the second of two events scheduled for 2018. Doctors, nurses, patients, and caregivers met in Manhattan to discuss the disease, current treatments, and cutting-edge tactics aimed at helping mesothelioma patients live longer, better lives.

Continue Reading »

Next >

Search the MCA Blog:

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide